For individuals with a high (>20%) 10-year ASCVD risk estimate who are aged 40 to 75 years with HIV, the panel recommendations are similar to the general population and recommend initiating high-intensity statin therapy. Similarly, for individuals with HIV aged 20 to 75 years with low-densit...
BACKGROUND: In November 2013, the American College of Cardiology and the American Heart Association released new cholesterol guidelines. Implications of these new guidelines for statin prescription remain uncertain, particularly in individuals already on statin therapy.Nguyen, VincentdeGoma, Emil M.Hossain...
Comparison of ACC/AHA vs ESC Guidelines for Primary Prevention Statin TherapyJelena PavlovićPhilip GreenlandJaap W. DeckersJasper J. BrugtsMaryam KavousiKlodian DhanaM. Arfan IkramAlbert HofmanBruno H. StrickerOscar H. Franco
" states Dr. Miedema. "Instead, the new guidelines recommend focusing statin therapy on the individuals that are at the highest risk for heart attack and stroke, even if theircholesterol levelsare within normal limits."
Unmet need for primary prevention in individuals with hypertriglyceridaemia not eligible for statin therapy according to European Society of Cardiology/Eur... sTo identify individuals at high risk of atherosclerotic cardiovascular disease (ASCVD), who are not definite statin eligible according to the ...
Eligibility for statin therapy in primary prevention: discrepancies using different guidelines in a population-based study in SwitzerlandDavid NanchenArnaud ChioleroJacques CornuzMathieu FirmannManuel MarquesVidal PedroVincent MooserFred PaccaudGérard Waeber...
The new guidelines advocate for more aggressive treatment with statin therapy and getting LDL cholesterol counts, commonly referred to as “bad cholesterol” to your target level –- in general, less than 100mg/dL; for those with risk factors, less than 70mg/dL. (M...
CONTEXT: The recommendation for statin therapy for the prevention of cardiovascular disease is expanded in the 2013 guidelines of the American College of Cardiology and the American Heart Association (ACC/AHA); nevertheless, the research... Javier,Sanz - 《Journal of the American College of Cardiolo...
When non-statins are considered for additional LDL-C lowering, ezetimibe is the only non-statin clearly shown to further reduce ASCVD risk when added to background statin therapy.doi:10.1007/s11910-016-0621-1Dandapat, SudeeptaDepartment of Neurology, University of Iowa, Iowa City, IA, USA;...
Forty-eight of 86 patients requiring statins were placed on the correct intensity statin using the 2013 guidelines. Regardless of which guideline, a majority of patients required statin therapy.A moderate agreement was found between both guidelines in terms of statin use when applied to an patient...